Yifang Eva Pan (Eva Y Pan, Eva Pan)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Combination Therapy

Metastatic Renal Cell Carcinoma

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

The Annals of pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yifang Eva Pan, Annette Hood, Hiba Ahmad, Gary Altwerger
Real-World Efficacy and Safety of PARP Inhibitors in Recurrent Ovarian Cancer Patients With Somatic BRCA and Other Homologous Recombination Gene Mutations. The Annals of pharmacotherapy (2023)
Nadya J Jammal, Yifang Eva Pan, Michael Hurwitz, Rebecca B Abramovitz
Outcomes of combination therapy with tyrosine kinase inhibitors and immune checkpoint inhibitors in metastatic renal cell carcinoma - A retrospective study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (3) (2019)
Yifang Eva Pan, Man Yee Merl, Katherine Lin
The impact of corticosteroid use during anti-PD1 treatment. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (4) (2019)